NP / PA
Hutton, Meredith
Hutton, Meredith was paid $242K by Medicaid between Jan 2018 and Nov 2020, across 34 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoHUTTON, MEREDITH
LAWRENCEBURG, TN 38464
LAWRENCEBURG, TN 38464
33aNPI1861802407assigned 05/05/2014
33bProvider typePrimary Care Nurse Practitioner
28Total paid$242K
24GClaims24,403
24DCodes billed34
24AFirst – last monthJan 2018 – Nov 2020
Compared with peers
Next to other Primary Care Nurse Practitioner providers in Tennessee
Rank by total paid#8 of 31
Median peer was paid$35K
This provider vs. median6.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,489 | $98K | |
| 2019 | 8,752 | $84K | |
| 2020 | 3,162 | $61K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 3,331 | 2,658 | $98K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 2,589 | 2,007 | $90K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 7.3% | 1,329 | 1,006 | $18K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.9% | 1,594 | 650 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.8% | 527 | 449 | $4K |
| 1160F | 1.3% | 3,978 | 2,791 | $3K | |
| 1159F | 1.3% | 3,982 | 2,792 | $3K | |
| 3008F | <1% | 2,900 | 2,037 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 198 | 148 | $2K |
| 81002 | <1% | 901 | 707 | $1K | |
| 97802 | <1% | 309 | 216 | $1K | |
| 99402 | <1% | 232 | 167 | $1K |
22 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 17 | $971.86 |
| 96127 | <1% | 229 | $718.22 | |
| 99173 | <1% | 263 | $717.54 | |
| 92551 | <1% | 191 | $675.13 | |
| 93000 | <1% | 62 | $546.93 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 225 | $360.57 |
| 99406 | <1% | 99 | $330.68 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 19 | $285.95 |
| 82962 | <1% | 165 | $187.05 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 18 | $171.01 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 492 | $159.99 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 106 | $147.94 |
| 99408 | <1% | 21 | $124.00 | |
| 94760 | <1% | 122 | $117.15 | |
| 90756 | <1% | 13 | $87.62 | |
| 95117 | <1% | 23 | $79.37 | |
| 36416 | <1% | 33 | $23.45 | |
| 3078F | <1% | 12 | $10.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 52 | $1.78 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 259 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 98 | $0.00 |
| 99080 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.